111 related articles for article (PubMed ID: 10123645)
1. Home infusion depresses Medical Care revenues.
Lutz S
Mod Healthc; 1993 Jan; 23(3):12. PubMed ID: 10123645
[No Abstract] [Full Text] [Related]
2. Home i.v. therapy companies target insurers, HMOs for future growth.
Lutz S
Mod Healthc; 1987 Mar; 17(6):96, 99. PubMed ID: 10281052
[No Abstract] [Full Text] [Related]
3. Home infusion therapy: comparison of costs for intravenous immunoglobulin.
Bielory L; Long GC
N J Med; 1993 Jul; 90(7):512-5. PubMed ID: 8355890
[TBL] [Abstract][Full Text] [Related]
4. The home infusion industry: patients' angel or their ruthless plunderer?
Margolis RE
Healthspan; 1993 Jun; 10(6):18-20. PubMed ID: 10127303
[No Abstract] [Full Text] [Related]
5. Home infusion therapy meets managed care: confrontation or cooperation.
Winters RW
Med Interface; 1994 Jul; 7(7):72-4, 85. PubMed ID: 10135994
[TBL] [Abstract][Full Text] [Related]
6. Home intravenous drug therapy under Medicare.
Leader S
Pride Inst J Long Term Home Health Care; 1989; 8(3):8-14. PubMed ID: 10303820
[No Abstract] [Full Text] [Related]
7. T2 news worsens with poor earnings.
Burns J
Mod Healthc; 1993 Aug; 23(35):35. PubMed ID: 10127940
[No Abstract] [Full Text] [Related]
8. Reserve fund drives Coram loss.
Burns J
Mod Healthc; 1994 Aug; 24(34):20-1. PubMed ID: 10135687
[No Abstract] [Full Text] [Related]
9. Home care forum: cost viewpoints.
Weinstein SM
NITA; 1987; 10(6):401-9. PubMed ID: 3320816
[No Abstract] [Full Text] [Related]
10. Bears circle Medical Care America.
Lutz S
Mod Healthc; 1993 Mar; 23(10):17. PubMed ID: 10124321
[No Abstract] [Full Text] [Related]
11. A high-priced hookup.
Lord M
US News World Rep; 1994 May; 116(18):63-4, 67-9. PubMed ID: 10133811
[TBL] [Abstract][Full Text] [Related]
12. Home iv therapy benefit of the Catastrophic Coverage Act: it's impact on home care providers.
Marren J; Rodgers B; Dishon M
Pride Inst J Long Term Home Health Care; 1989; 8(3):15-8. PubMed ID: 10303818
[No Abstract] [Full Text] [Related]
13. Hospitals poised to offer in-home i.v. therapy.
Robinson ML
Hospitals; 1989 Jul; 63(14):16, 20. PubMed ID: 2666297
[No Abstract] [Full Text] [Related]
14. Unissued rules worry home care providers.
Lutz S
Mod Healthc; 1989 Sep; 19(35):34, 36. PubMed ID: 10303811
[No Abstract] [Full Text] [Related]
15. Home i.v. market is healthy hospital option.
Souhrada L
Hospitals; 1989 Feb; 63(3):54. PubMed ID: 2912857
[No Abstract] [Full Text] [Related]
16. Homedco and Abbey among companies that have viewed T2's books.
Burns J
Mod Healthc; 1994 Jan; 24(5):10. PubMed ID: 10131365
[No Abstract] [Full Text] [Related]
17. Cost-effectiveness issues for home i.v. therapy in the United States.
Allen R
Hosp Formul; 1993 Jan; 28 Suppl 1():37-40. PubMed ID: 10123837
[TBL] [Abstract][Full Text] [Related]
18. Medicare program; payment for home intravenous drug therapy services--HCFA. Proposed rule.
Fed Regist; 1989 Nov; 54(215):46938-53. PubMed ID: 10303985
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplants. Managing BMT patients in alternate site health care settings with infusion therapy.
Buchsel PC
Contin Care; 1992; 11(1):27-9; 36. PubMed ID: 10150100
[No Abstract] [Full Text] [Related]
20. Government targets fraud in home infusion industry.
Weissenstein E
Mod Healthc; 1993 Sep; 23(37):14. PubMed ID: 10128181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
